Deng Zhenling相关文献与解析，生知库 | 链接生命科学的每一步

Time-resolved fluoroimmunoassay improves sensitivity in the diagnosis of primary membranous nephropathy with low phospholipase A2 receptor antibody titer

时间分辨荧光免疫测定法提高了低磷脂酶A2受体抗体滴度原发性膜性肾病诊断的敏感性

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-17354-x

Deng, Zhenling; Qu, Yuanlin; Liu, Yuting; Zheng, Tianyu; Gao, Yueming; Huang, Biao; Wang, Yue; Zheng, Danxia

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study

通过群体药代动力学和药效学研究优化利妥昔单抗治疗原发性膜性肾病的剂量

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2024.1197651

Liang, Hao; Deng, Zhenling; Niu, Shu; Kong, Weijie; Liu, Yang; Wang, Song; Li, Haiyan; Wang, Yue; Zheng, Danxia; Liu, Dongyang

发表日期：2024

文献求助收藏

Molecular Differences in Glomerular Compartment to Distinguish Immunoglobulin A Nephropathy and Lupus Nephritis.

肾小球区室的分子差异可区分免疫球蛋白A肾病和狼疮性肾炎

期刊:Journal of Inflammation Research

影响因子:4.1

doi:10.2147/JIR.S496138

Zhang Haidong, Li Sicong, Deng Zhenling, Wang Yue

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

每月小剂量利妥昔单抗治疗原发性抗PLA2R阳性膜性肾病：个体化治疗方案

期刊:BMC Nephrology

影响因子:2.4

doi:10.1186/s12882-023-03206-1

Wang, Song; Deng, Zhenling; Wang, Yue; Bao, Wenhan; Zhou, Sijia; Cui, Zhuan; Zheng, Danxia

发表日期：2023

文献求助收藏

Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature

特发性多中心性卡斯尔曼病合并干燥综合征和继发性膜性肾病：病例报告及文献复习

期刊:BMC Nephrology

影响因子:2.4

doi:10.1186/s12882-020-02191-z

Pan, Yuejuan; Cui, Zhuan; Wang, Song; Zheng, Danxia; Deng, Zhenling; Tian, Xinyu; Guo, Hongxia; Bao, Wenhan; Zhou, Sijia; Wang, Yue

Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model

在CT26荷瘤小鼠模型中，反复使用5-氟尿嘧啶化疗会损害细胞毒性T细胞的抗肿瘤功能。

期刊:BMC Immunology

影响因子:2.7

doi:10.1186/s12865-016-0167-7

Wu, Yanhong; Deng, Zhenling; Wang, Huiru; Ma, Wenbo; Zhou, Chunxia; Zhang, Shuren

Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

针对前列腺癌干细胞抗原EpCAM的过继性T细胞疗法

期刊:BMC Immunology

影响因子:2.7

doi:10.1186/s12865-014-0064-x

Deng, Zhenling; Wu, Yanhong; Ma, Wenbo; Zhang, Shuren; Zhang, Yu-Qian

A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4

一种新型的oHSV-1病毒，通过肿瘤特异性启动子调控ICP4的表达，靶向端粒酶逆转录酶阳性癌细胞。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.3884

Zhang, Wen; Ge, Keli; Zhao, Qian; Zhuang, Xiufen; Deng, Zhenling; Liu, Lingling; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Binlei

IgA expressed by glomerular mesangial cells is involved in the pathogenesis of IgA nephropathy.

肾小球系膜细胞表达的 IgA 与 IgA 肾病的发生发展有关。

Time-resolved fluoroimmunoassay improves sensitivity in the diagnosis of primary membranous nephropathy with low phospholipase A2 receptor antibody titer

时间分辨荧光免疫测定法提高了低磷脂酶A2受体抗体滴度原发性膜性肾病诊断的敏感性

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study

通过群体药代动力学和药效学研究优化利妥昔单抗治疗原发性膜性肾病的剂量

Molecular Differences in Glomerular Compartment to Distinguish Immunoglobulin A Nephropathy and Lupus Nephritis.

肾小球区室的分子差异可区分免疫球蛋白A肾病和狼疮性肾炎

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach

每月小剂量利妥昔单抗治疗原发性抗PLA2R阳性膜性肾病：个体化治疗方案

Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature

特发性多中心性卡斯尔曼病合并干燥综合征和继发性膜性肾病：病例报告及文献复习

Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model

在CT26荷瘤小鼠模型中，反复使用5-氟尿嘧啶化疗会损害细胞毒性T细胞的抗肿瘤功能。

Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

针对前列腺癌干细胞抗原EpCAM的过继性T细胞疗法

A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4

一种新型的oHSV-1病毒，通过肿瘤特异性启动子调控ICP4的表达，靶向端粒酶逆转录酶阳性癌细胞。